The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs-Reference-Cited by-同舟云学术

The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs

Published:2018-09-29 Issue:10 Volume:11 Page:999-1030
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Roncero Carlos¹²,Villegas Jose Luis³,Martínez-Rebollar Maria⁴,Buti Maria⁵

Affiliation:

1. Psychiatric Service, University of Salamanca Health Care Complex (Complejo Asistencial Universitario de Salamanca), Salamanca, Spain

2. Psyciatric Departament, Institute of Biomedicine of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain

3. Psychiatric Unit Topas Prison, Psychiatric Service, University of Salamanca Health Care Complex, Salamanca, Spain

4. HIV Unit, Infectious Diseases Service, Hospital Clinic, Barcelona, Spain

5. Liver Unit, Hospital Universitario Vall d’Hebron and Ciber-ehd, Instituto Carlos III, Barcelona, Spain

Funder

Merck Sharp & Dohme Spain

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2018.1519392

Reference55 articles.

1. EASL Recommendations on Treatment of Hepatitis C 2018

2. Evolving epidemiology of hepatitis C virus

3. Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction

4. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions

5. Zepatier® SmPC. [cited 2018 Mar]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004126/WC500211235.pdf

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir;Alimentary Pharmacology & Therapeutics;2024-05-02

2. Patient‐centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in Taiwan;The Kaohsiung Journal of Medical Sciences;2023-11-09

3. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología;2023-05

4. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología (English Edition);2023-05

5. Resource utilization associated with the management of potential interactions between direct-acting antivirals for chronic hepatitis C treatment and cardiovascular and central nervous system drugs;Economía de la Salud;2022-12